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The liver is the largest and most vulnerable organ in the body, 
several factors can cause liver cirrhosis and the onset of 
hepatocellular carcinoma. This study aims to investigate the 
possibility for erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) as 
adenosine deaminase inhibitor which reduces liver injury, 
neutrophil infiltration and the levels of proinflammatory cytokines 
and also it is considering as a target of liver cirrhosis and 
beginning of hepatocellular carcinoma protective, quercetin which 
is one of the most common flavonoids has an antioxidant, 
antitumor and chemopreventive effect on the liver-induced 
preneoplastic lesions and their combination against thioacetamide 
as a hepatotoxic and a carcinogenic compound. Biochemical, 
histopathological and immunohistochemical studies were carried 
out on male albino rats model to evaluate this possibility. 
Thioacetamide-treated rats showed a significant increase in liver 
functions tests (P = 8.6 X 10-7 for alanine transaminase, P = 1.89 
X 10-8 for γ-glutamic transpeptidase and P = 8.8 X 10-13 for total 
bilirubin), α-fetoprotein (P = 7.95 X 10-13) and the number of 
Ki67+ cells (P = 3.0 X 10-6), and caused an elevation in the 
expression of inducible nitric oxide synthase (iNOS) and Pan-
cytokeratin (Pan-CK) in hepatic tissue of rats. 
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Cirrhosis is the most common form of liver pathology that leads to the 
development of hepatocellular carcinoma (HCC), a type of primary liver cancer 
that is considered the most lethal cancer in the world(1). Most cases of cirrhosis 
and the beginning of HCC are attributable to infections caused by hepatitis B and 
C viruses (2), obesity, iron overload, environmental pollutants and several dietary 
carcinogens, such as aflatoxins, thioacetamide and nitrosamines (3). These insults 
are initiated by liver damage that leads to the release of inflammatory cells, 
cytokines, growth factors and reactive oxygen species (ROS) (4, 5) which leads to 
cytotoxicity, mutagenicity and carcinogenicity.  
Thioacetamide (TAA) is an organic compound with the formula CH3CSNH2 
which is used in rubber, chemicals, pesticides (6), and in making metal salt 
nanoparticles (7). It is a potent hepatotoxin that usually causes acute or chronic 
liver diseases, cirrhosis, liver cell adenomas, and HCC subsequently in experimental 
animal models (8). TAA undergoes an extensive metabolism that leads to the 
formation of sulfoxide and sulfone which circulate through vital organs like liver, 
kidney and bone marrow (9). The main site of TAA metabolism is the liver and 
the production of ROS considers the main reason for TAA toxicity in the liver 
(10).  
Adenosine deaminase (ADA), is an important enzyme, found in all mammalian 
cells (11). Erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA), an ADA inhibitor, is a 
crystalline compound soluble in organic solvents such as DMSO and is less toxic 
than other ADA inhibitors because it keeps the cellular capacity for the 
deamination of purines nucleotides like (adenosine monophosphate (AMP), 
adenosine diphosphate (ADP) and adenosine triphosphate (ATP)) (12). EHNA 
prevents adenosine breakdown so it can raise adenosine concentration which has 
anti-inflammatory activities and induces apoptosis in a variety of cancer cells 
mediated by intrinsic and/or extrinsic pathways (13). For the intrinsic pathway, 
extracellular adenosine is taken into cells by adenosine transporters and converted 
to adenosine monophosphate (AMP) by adenosine kinase to activate AMP-
activated protein kinase (AMPK), responsible for apoptosis in lung, breast cancer 
cells and hepatoma cells (14). For the extrinsic pathway, adenosine release from 
cells to the plasma membranes of neighboring cells, where it binds to specific 
adenosine receptors (A1, A2A, A2B, and A3) and causes apoptosis in a variety of 
cancer cells according to the concentration of adenosine and the type of receptors 
(13). 
In conclusion results of the present study showed that treatment 
with quercetin, EHNA or their combination protect liver from 
development of HCC by attenuated changes in liver functions 
tests, expression of iNOS, Ki67 and Pan-CK, and histopathological 
changes induced by thioacetamide 
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Quercetin (QU) is one of the most common flavonoids which is found in several 
fruits and vegetables, has various pharmacological actions including, hepato-
protective, reno-protective and neuroprotective effects (15). It has a beneficial effect 
on liver diseases and tumors in animal models and induces apoptosis of cancer cells 
by disruption of the mitochondria and release of cytochrome c and the activation 
of caspases (16, 17).  Moreover, QU can inhibit metabolic activity and induce 
apoptosis in liver cancer cell lines like HepG2, HuH7, and Hep3B2 (18). It has 
potential chemopreventive or therapeutic effects in the treatment of liver cancer 
(19).     
    In our study, we investigate the potential role of QU, EHNA or their 
combination on TAA-induced liver toxicity in male rats using different 
histopathological, biochemical and molecular techniques. 
 
 
Materials and methods 
 
Chemicals   
 
Thioacetamide (TAA), Quercetin (QU) and adenosine deaminase inhibitor 
erythro- 9-(2-hydroxy-3-nonyl) adenine were obtained from Sigma Chemical Co. 
(St. Louis, MO, USA). Enzyme immunoassay kit used for measurement of α-
fetoprotein (AFP) was purchased from Bioscience, South San Francisco. kits for 
the determination of alanine transaminase (ALT), γ- glutamic transpeptidase 
(GGT) were purchased from Agappe diagnostics Switzerland, GMBH. Total 
bilirubin (TB) measurement kit was purchased from Diamond diagnostic, Egypt. 
All other chemicals were of the highest purity commercially available. 
 
Animals   
 
Fifty adult male albino rats (120-150 g) were obtained from the animal house 
of the Faculty of Medicine, Assuit University, Assuit, Egypt. Rats were housed in 
cages and were kept at room temperature (30±30C) with a normal 12/12 h 
light/dark cycle and supplemented with standard commercial pellets for feeding 
water and labium. All experiments followed protocols approved by the Institutional 
Animal Care and Life Committee, Assiut University. 
 
Experimental groups   
 
Animals were divided into 5 groups of 10 animals each. Group I: served as a 
control was intraperitoneally (IP) injected with dimethyl sulfoxide (DMSO). Group 
II: rats were IP injected with TAA (200 mg/kg) twice a week for 3 months (20). 
Group III: rats were IP injected with QU (100 mg/kg) 30 min before TAA injection 
(21). Group IV: rats were IP injected with EHNA (150 µM/kg) 30 min before TAA 
injection (22). Group V: rats were IP injected with QU (100 mg/kg) and EHNA 
(150 µM/kg) 30 min before TAA injection.  
 
Collection and preparation of the samples for biochemical analysis  
 
At the end time of the experiment, rats were sacrificed under anesthesia and 
were used for the collection of blood and liver. Blood was collected in tubes 
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containing EDTA, centrifuged at 3000 rpm for 10 minutes for separation of plasma 
for biochemical analysis. 
 
Estimation of AFP as a liver tumor marker 
     
Plasma AFP level as marker of liver tumor was estimated by enzyme 
immunoassay test kit for quantitative determination of AFP from Bioscience, 
South San Francisco. (Catalog Number: 10101). In brief, coated wells in the holder 
were labeled. 20 µl of samples, standard and control were added to appropriate 
wells followed by addition of 100 µl of zero buffer into each well. Samples in wells 
were mixed for 20 sec and incubated at room temperature (RT) for 30 min. 
Incubation mixture was removed by flicking plate content into a waste container. 
Wells were washed 5 times by washing buffer (1X). Wells were stroked sharply 
onto paper towel to remove all residual water droplets. 150 µl of enzyme conjugated 
reagent were added into each well, gently mixed for 5 seconds and incubated at 
RT for 30 min. The incubation mixture was removed by flicking plate content into 
a waste container. Each well was washed 5 times by washing buffer (1X). The wells 
were stroked sharply onto paper towel to remove all residual water droplets. 100 
µl of TMP substrate were added into each well, gently mixed for 5 seconds and 
incubated at RT for 20 min. 100 µl of stop solution were added to each well to stop 
reaction. Wells were gently mixed for 30 second to make sure blue color change to 
yellow color. Optical density was readied at 450 nm within 15 min. and the 
concentration was calculated by internal calibration standard using VIDAS 
microliter reader. 
 
Estimation of ALT 
  
Plasma ALT activity was determined calorimetrically using commercial kit from 
Agappe Diagnostics, Switzerland, GMBH. In brief, working reagent was prepared 
by mixing R1 and R2 in 4:1 ratio. Large glass tubes were labeled for each sample. 
1000 µl of working reagent and 100 µl of samples were added in each tube. All 
tubes were mixed and incubated for 1 min at 37ºC. Change in absorbance per min 
for 3 min (∆OD/min) was detected. ALT activity (U/L) was calculated with the 
following formula: ALT activity (U/L) = (∆OD /min) X 1745. 
 
Estimation of GGT 
      
Plasma GGT activity was determined calorimetrically using commercial kit 
from Agappe Diagnostics Switzerland, GMBH. In brief,  working reagent was 
prepared by mixing R1 and R2 in 4:1 ratio. Large glass tubes were labeled for each 
sample. 1.0 ml of working reagent and 100 µl of samples were added in each tube. 
All tubes were mixed and incubated for 1 min at 37ºC. Change in absorbance per 
min for 3 min (∆OD/min) was detected. GGT activity (U/L) was calculated with 
the following formula: GGT activity (U/L) = (∆OD /min) X 1158. 
 
 Estimation of TB 
     
Total bilirubin concentration in plasma was determined using commercial kit 
from Diamond Diagnostic, Egypt. In brief, large glass tubes were labeled for each 
sample, sample blank and blank. 50 µl sample and 1.0 ml normal saline were added 
to each sample blank tubes. 50 µl sample and 1.0 ml reagent (R) were added in 
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sample tubes and 1.0 ml of reagent (R) was added in blank tube, respectively. All 
tubes were mixed and incubated for 3 min at room temperature. Absorbance of 
specimen (A sample) and sample blank (A sample blank) against reagent blank 
was measured at 546 nm. Total bilirubin concentration was calculated with the 
following formulas: Total bilirubin concentration (mg/dl) = ∆A sample X 28 where 
∆A Sample = A sample – A sample blank.  
 
 
Histopathological examination of liver tissue and quantification of 
liver cirrhosis 
          
Liver was washed in phosphate buffer saline (PBS) pH 7.4 and morphologically 
examined. The other part of liver was preserved in 10 % neutral formalin solution 
for fixation. The fixed parts were trimmed, washed and dehydrated in ascending 
grades of alcohol. Tissue specimens were then cleared in xylene, embedded in 
paraffin and sectioned at 4-6 µm thickness. Slides were deparaffinized in xyelen, 
rehydrated and placed in hematoxylin stain for 1 min then washed for 5 min in 
running tap water. Slides were then stained with eosin, quickly rinsed in distilled 
water, dehydrated in ascending grades of alcohol and mounted. Slides were imaged 
using Olympus BX60 microscope and digital camera system (DP70, Olympus, 
Tokyo, Japan) under X200 magnification. For the quantification of liver cirrhosis, 
slides were stained in Picro-Sirius Red as described previously in (23). Brifly, slides 
were deparaffinized in xyelen, rehydrated and placed in Picro Sirius Red solution 
for 1 hr at RT. Slides were washed in two changes of acidified water for 5 min each 
at RT. Slides were dehydrated in three changes of 100% ethanol, cleared in xylene 
and mounted. Images of liver sections in each group were acquired by using the 
Olympus BX60 microscope and digital camera system (DP70, Olympus, Tokyo, 
Japan). All images were analyzed using the ImageJ software (version 1.45b; 
National Institutes of Health, Bethesda, MD, USA). The whole area and the fibrosis 
area stained with Picro Sirius Red were measured. The percentage (%) of intensity 
was calculated with the following formula: (fibrosis area / whole area) X 100.  
 
Immunohistochemical studies of Ki67, Pan-CK and iNOS  
     
Liver tissue sections were deparaffinized by placing them in aseries of xylene, 
rehydrated, and washed in (PBS) pH 7.4. For antigen retrieval, slides were 
incubated for 45 min in 10 mM citrate buffer at pH 6.0 and heated at 98˚C. To 
block endogenous peroxidase activity, slides were incubated in PBS containing 3% 
H2O2 for 45 min. Slides were then incubated for 1 h at room temperature or 
overnight at 40C with rat polyclonal antibodies specific for Ki67 at a dilution of 
(1:300), Pan-CK at a dilution of (1:100) and iNOS at a dilution of (1:20. Slides 
were washed with distilled water, followed by PBS then incubated with horseradish 
peroxidase-conjugated secondary antibodies for 15 min. Slides were subsequently 
washed twice with PBS. Then, the peroxidase reaction was developed with DAB-
chromogen, and the slides were washed for 5 min in tap water and counterstained 
with Mayer hematoxylin from (Dako) for 5 min and then dehydrated, mounted 
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Statistical analysis    
   
All data were statistically analyzed using one-way analysis of variance 
(ANOVA), the Tukey-HSD test was used to find the significant difference between 
groups at P < 0.05. The results were analyzed as mean ± SEM (standard error of 
the mean). These analyses were carried out using Statistical Package for Social 





Treatment of EHNA and QU reduced the high level of AFP and liver 
function tests induced by TAA  
 
The AFP level is the most common predictor for HCC. As compared to control 
rats the level of AFP was significantly elevated in TAA-treated group. Groups of 
rats co-treated with QU, EHNA and their combination showed improvement in the 
AFP level in comparison to TAA-treated group, it also showed that no significant 
difference between the treatment with QU, EHNA and control group (Fig. 1A). As 
compared to control rats the activity of ALT was markedly elevated in HCC-
induced group. Groups of rats co-treated with QU, EHNA and their combination 
showed improvement in the activity of ALT in comparison to TAA-treated group 
but still higher than control (Fig. 1B). As compared to control rats the activity of 
GGT and the level of TB were markedly elevated in HCC-induced group. Groups 
of rats co-treated with QU, EHNA and their combination showed improvement in 
the activity of GGT and the level of TB in comparison to TAA-treated group but 
still higher than control but it also showed that treatment with EHNA gave a 
better result than treatment with QU and their combination (Fig. 1C and D). 
 
Table 1. Plasma level of tumor marker AFP and liver functions (ALT, GGT and TB) of control and different 
treated groups. 
 
Results presented as mean ± SEM, the different letters (a, b, c and d) indicate significant difference at P < 0.05 
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Figure. 1. Level of AFP (A), activities of ALT and GGT (B and C) and the level of TB (D) in plasma of control and 
different treated groups. Results presented as mean ± SEM, the different letters (a, b, c and d) indicate significant 
difference at p < 0.05 between different groups, where n=6. 
 
Treatment with EHNA or QU recovered the histopathological 
alterations in hepatic tissues induced by TAA 
 
Liver of control rats showed normal lobular architecture with distinct hepatic 
cells, sinusoidal space and a central vein (Fig. 2A, arrow). Liver of TAA-treated 
group showed hepatocytes necrosis (Fig. 2B), loss of normal lobular architecture 
with the presence of regenerating nodules separated by fibrous septa (Fig. 2C, 
arrow), sinusoidal dilatation and adenoma (Fig. 2D, arrow), progressive increase in 
the number of cells having large nuclei and open chromatin pattern with 
eosinophilic staining of their cytoplasm were observed (clear cells) (Fig. 2E), giant 
hepatocytes with enlargement and darkening of nuclei with clumping of chromatin 
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(Fig. 2F, arrow), the proliferation of bile duct and increased mitotic figures in 
portal areas (Fig. 2G, arrow). Liver of rats co-treated with QU, EHNA and their 
combination (Fig. 2H-J) showed marked recovery in hepatic morphology as the 
large fibrous septa or collagen deposition was reduced, the proliferation of bile duct, 
clear cells, pyknotic nuclei and lymphocytes infiltration were decreased compared 




Figure 2. Hepatic tissues stained with H&E images (X200), control group (A), TAA-treated group (B-G), TAA+QU 
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EHNA and QU administration decreased liver cirrhosis induced by 
TAA 
 
Liver of the control group showed normal hepatic structure and no collagen 
deposition (Fig. 3a). In rats treated with TAA showed extended collagen deposition 
and large septa forming hepatic pseudo lobules compared with the control group  
(Fig. 3b, arrows). Liver of rats co-treated with QU, EHNA and their combination 
showed marked reduction in collagen deposition and decrease in hepatic fibrosis 
compared with TAA-treated group (Fig. 3c-e, arrow).      
 
  
              
 
Figure. 3. (A) Collagen deposition in liver fibrosis induced by TAA in rats stained with Picro-Sirius Red (X100). 
Control group (a), TAA-treated group (b), TAA+QU group (c), TAA+EHNA group (d) and TAA+QU+EHNA 
group (e). (B) Quantitative analysis of Picro Sirius Red staining as mean ± SEM in liver tissue of control and 
different treated groups, the different letters (a and b) indicate significant difference at p < 0.05 between different 
groups, where n =6. 
 
EHNA and QU reduced the expression of iNOS  
 
The expression response of iNOS in liver of all groups was analyzed using 
immunohistochemistry. In the control group the expression area of iNOS was very 
low (Fig. 4A), in the TAA-treated group there was elevation of iNOS protein 
expression compared with the control group (Fig. 4B). On the other hand, co-
treatment with QU, EHNA and their combination decreased the expression of iNOS 
compared with TAA-treated group but still higher than control but it also showed 
that treatment with EHNA gave a better result than the treatment with QU and 
their combination (Fig. 4C-E). 
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Figure 4. Immunohistochemical staining showed the expression of iNOS labeling (X200) in normal rat tissue (A) TAA-
treated group (B), TAA+QU group (C), TAA+EHNA group (D) and TAA+QU+EHNA group (E). 
 
EHNA and QU reduced the proliferation in hepatic tissue 
 
Immunohistochemistry with anti-Ki67 antibody was used to assess cell division 
in the liver of all groups. Ki67 immunoreactivity was localized in the nucleolus and 
nucleus mainly in the nuclear membrane. In the control group the expression area 
of Ki67 was very low in the nucleus of hepatocytes and cholangiocytes (Fig. 5a, 
arrow), in the TAA-treated group there was a massive increase in Ki67 labeled 
cells compared with the control group  (Fig. 5b, arrows). These dividing cells are 
mainly found in the nucleus of hyperplastic cholangiocytes (Fig. 5b, upper arrow) 
and in the nucleus of hepatocytes (Fig. 5b, lower arrow). On the other hand, co-
treatment with QU, EHNA and their combination caused a significant reduction 
in the expression area of Ki67 in the nucleus of hepatocytes and cholangiocytes 
compared with TAA-treated group but still higher than control (Fig. 5c-e) but it 
also showed that treatment with EHNA gave a better result than treatment with 
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Figure 5. (A) Immunohistochemical analysis of Ki67 showed the level of Ki67 (X200) labeling in the control group (a) 
TAA-treated group (b), TAA+QU group (c), TAA+EHNA group (d) and TAA+QU+EHNA group (e). (B) A graph 
demonstrates the quantifications of the percent of Ki67 labeled areas as mean ± SEM in liver tissue of control and 
different treated groups, the different letters (a, b, c and d) indicate significant difference at P < 0.05 between 
different groups, where n =6. 
 
EHNA and QU decreased the expression of Pan-CK, hepatocellular 
carcinoma and cholangiocarcinoma marker 
 
    Immunohistochemistry with anti-Pan-CK antibody was used to investigate 
HCC and cholangiocarcinoma (CCA) in the liver of all groups. In the control group, 
no Pan-CK-labeled in hepatocytes and the epithelium of bile ducts  (Fig. 6a and 
b, arrow), in the TAA-treated group there was a massive increase of Pan-CK-
labeled in hepatocytes  (Fig. 6c, arrow) and in the epithelium of dysplastic bile 
ducts  (Fig. 6d, arrow), in TAA+QU group the Pan-CK-labeled in hepatocytes 
and in the epithelium of bile ducts were reduced  (Fig. 6e and f, arrows), in 
TAA+EHNA group there were only a few Pan-CK-labeled in hepatocytes and in 
the epithelium of bile ducts  (Fig. 6g and h, arrow), in TAA+QU+EHNA group 
there were also very few Pan-CK-labeled in hepatocytes and in the epithelium of 
bile ducts (Fig. 6i and j, arrow), but it also showed that treatment with EHNA 
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Figure 6. (A) Immunohistochemical analysis of Pan-CK (X200) labeling in control group (a and b), TAA-treated 
group (c and d), TAA+QU group (e and f), TAA+EHNA group (g and h) and TAA+QU+EHNA group (i and j). (B) 
A graph demonstrates the quantifications of the percent of Pan-CK labeled areas as mean ± SEM in liver tissue of 
control and different treated groups, the different letters (a, b, c and d) indicate significant difference at p < 0.05 




     
In the present study, we found that adenonsine deaminas inhibitor and 
quercetin protect the liver from cirrhosis and the initiation of hepatocellular 
carcinoma caused by thioacetamide toxicity.  The liver is more prone to toxic 
injuries than other organs, TAA was listed in the (Third Annual Report on 
Carcinogens) and an additional study has been identified (25), which found that 
TAA induced damage, DNA repair and uncontrol apoptosis in the liver, and also 
caused hepatic cell proliferation, neovascularization, activation of oncogenes, and 
inactivation of tumor suppressor genes are all involved in liver cirrhosis and the 
formation of HCC and CCA (26). AFP is a major mammalian embryo-specific and 
tumor-associated protein that is also produced during the embryonic period by the 
visceral endoderm of the gestational sac and, later by the liver (27, 28). AFP level 
measurement may be useful as a sensitive marker system for the early detection of 
recurring HCC, even before the clinical symptoms are evident (29). The current 
results showed that the AFP level was significantly elevated (P = 7.95 X 10-13) in 
TAA-treated group that is may be due to hepatic intoxication that caused 
alterations in the hepatocytes and increased transcription of AFP gene or 
posttranslational modification affecting AFP production (30). Also, our results 
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showed that the administration of TAA significantly elevated the activities of ALT 
(P = 8.6 X 10-7) and GGT (P = 1.89 X 10-8), and the level of TB (P = 8.8 X 10-
13). This elevation due to marked hepatic membrane damage (31) or may be due 
to the possible effect of tumor initiation on hepatic tissues (32). Moreover, GGT 
enzyme is used as a tumor marker (33), it is detected in altered hepatic foci induced 
by carcinogens cause initial lesions until the tumor formation in most animal 
models (34).  Elevated GGT activity was confirmed by the increases of plasma TB 
level due to blockage of bile ducts (35). Co-treatment with QU and EHNA 
decreased AFP, ALT, GGT activities and TB level due to their ability to inhibit 
the transcription of AFP gene (36), also due to they have antitumor and 
hepatotoxic preventing effects that preserved cell membrane stabilization (37). But 
their combination didn’t give a better result due to QU may work as adenosine 
antagonist which has a high in vitro and in vivo affinity for the A1 and A2A 
adenosine receptors (38).  
In TAA group the histopathological features and the Sirius Red staining showed 
severe liver cell damage, liver cirrhosis and preneoplastic lesions in rats supporting 
the observed changes in plasma analysis and these results are in agreement with 
(39). These features may be due to TAA has carcinogenic properties through 
different mechanisms: i) releasing of reactive oxygen species (ROS) which damages 
DNA, protein, and lipid molecules, ii) inducing mutations in proto-oncogenes 
leading to cell division, iii) inducing the proliferation of hepatocytes and 
hyperplasia of bile duct epithelium leading to the formation of microscopic 
precancerous lesions (40), also multiple injections of TAA were found to induce 
preneoplastic changes in rats in two stages: initially by enhancing apoptosis and 
then precancerous lesions are formed (41). After treatment with QU, EHNA and 
their combination, the recovery of histological features may be due to the potential 
chemopreventive of QU and EHNA (42). Also, EHNA may increase the adenosine 
concentration which has anti-inflammatory and antitumor activities by binding to 
its receptors (A1, A2A, A2B and A3) (13). In addition, QU may cause apoptosis 
in cancer cells by induction of stress proteins, disruption of mitochondrial, the 
release of cytochrome c, and activation of caspases (43), and also by cell cycle arrest 
in different cell types (17).  
Nitric oxide is a potent biological mediator that influences physiological 
processes in every organ and tissue and it is a free radical produced by hepatocytes 
after exposure to cytokines (44). It is rapidly oxidized in blood and tissues to form 
nitrate and nitrite (45). Our results showed an elevation in the hepatic iNOS 
protein expression in TAA-treated rats due to the inflammatory reaction (46, 47). 
These results are in line with (39, 48). Administration of QU or EHNA decreased 
the elevation of iNOS protein expression in hepatic tissue because they have 
powerful anti-inflammatory effects by inhibiting NOS gene expression (47). EHNA 
elevates endogenous adenosine concentrations which could provide the binding to 
(A2A) adenosine receptor results in anti-inflammatory effects, including the 
decreased neutrophil release of (ROS) (49). But their combination didn’t give a 
better result due to adenosine antagonistic effect of QU that has a high in vitro 
and in vivo affinity for the A1 and A2A adenosine receptors (38). 
Ki67 proteins were expressed during cell proliferation, it was highest at the 
G2/M phase of the cell cycle except for the G0 phase (50). The present study 
showed a significant elevation of Ki67 expression (P = 3 X 10-6 ) in the nucleus of 
liver cells and cholangiocytes of rats treated with TAA due to the higher mitotic 
activity (51), and it also might be that is an early event in the pathogenesis of 
hepatic neoplasia which is one of the most common features of liver cirrhosis 
supporting the observed changes in histopathological studies (52). (53) indicated 
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that the number of Ki67 positive cells was increased significantly due to paralleled 
c-met proto-oncogene overexpression. Treatment with QU or EHNA significantly 
reduced (P = 0.011 and P = 4.7 X 10-5, respectively) the number of Ki67 positive 
cells compare with TAA group. This may be because QU can inhibit the cell 
proliferation and the growth of different cancer cell lines by causing the arrest of 
cell cycle phases such as G2/M or G1 (54), and EHNA cause apoptosis of cancer 
cells by increasing the adenosine concentration which increases the inhibition of 
cell proliferation, invasion and metastasis of the tumor by interacting with a variety 
of cell signaling proteins (55). But their combination didn’t give a better result due 
to QU is adenosine antagonist which has ahigh in vitro and in vivo affinity for the 
A1 and A2A adenosine receptors (38).  
Pan-CK is the epithelial-specific tumor marker in liver cells and in the 
epithelium of bile ducts which is used for the identification of circulating tumor 
cells (56, 57). Moreover, the tumor cells can undergo the epithelial to mesenchymal 
transition, which can result in downregulation of epithelial cell-specific molecules 
including cytokeratins (25), and this transition may grant tumor cells to stem cell 
properties enabling self-renewal (58). Our study showed distinct staining for Pan-
CK in liver cells and in the epithelium of bile ducts of rats treated with TAA due 
to DNA damage caused genetic changes and up-regulation of the proto and 
oncogenes leading to uncontrolled cell division supporting the observed changes in 
Ki67 immunohistochemical analysis (41). (59) reported that TAA could induce 
liver `severe' bile duct proliferation and eventually CCA. The present results 
showed that the co-treatment with QU, EHNA and their combination significantly 
decreased the expression of Pan-CK (P = 7 X 10-5 and P = 7.12 X 10-7, respectively) 
due to QU has antitumor effects which inhibit the progression of hepatic 
carcinogenesis (60). Moreover, EHNA increases adenosine concentration by binding 





From this study it was found that treatment with EHNA alone and QU alone 
produced better results than treatment with both against TAA induced liver 
cirrhosis, initiation of HCC and CCA through decreased of iNOS, Ki67 and Pan-
CK expression. So that our results suggest that EHNA or QU can be recommended 
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